In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Pfizer is working on its seventh straight loss after failing near heavy resistance.
The $101 billion market cap pharma could be put in play or targeted by an activist investor soon.
This small-cap biotech name could have further to run.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.